Piramal Pharma’s division -- Piramal Critical Care (PCC) has launched new 10mg/10mL (1 mg/mL) concentration of Zinc Sulfate for Injection USP in the U.S. The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio.
FDA Confirms Paragraph IV Patent Litigation for Cupric Sulfate, Magnesium Sulfate, Selenious Acid, Zinc Sulfate Injection
Zydus' Generic Zinc Sulfate Receives Approval in the U.S.
Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
Enforcement Report - Week of August 14, 2019
Enforcement Report - Week of November 7, 2018
French regulators have identified another Indian API maker they say lacks just about every kind of good manufacturing practice needed to produce acceptable drugs, sanitation, data integrity and sample control. As a result, they have recommended the European Medicines Agency recall all of its products and not allow them to be used in any new drugs.
Government Caps Prices of 52 More Essential Drugs, Including Painkillers & Antibiotics